Nikitiuk BE

ORCID: 0000-0002-0768-6944 · 3 papers in corpus
2026
Could Serum CA125 Aid the Clinical Assessment of Volume Status of End-Stage Kidney Disease Patients Treated by Peritoneal Dialysis Patients?
Blood purification ·doi:10.1159/000553236

IntroductionVolume overload is a major cause of technique failure, morbidity and mortality for peritoneal dialysis patients (PD). Biomarkers could potentially aid the clinical assessment of patients. Recently, Cancer antigen 125 (CA125) has…

2024
On Whether Ca-125 Is the Answer for Diagnosing Overhydration, Particularly in End-Stage Kidney Disease Patients-A Systematic Review.
International journal of molecular sciences ·doi:10.3390/ijms25042192

Overhydration (OH) is a prevalent medical problem that occurs in patients with kidney failure, but a specific marker has still not been found. Patients requiring kidney replacement therapy suffer from a water imbalance, which is correlated …

2022
Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?
Obesity reviews : an official journal of the International Association for the Study of Obesity ·doi:10.1111/obr.13413

Obesity is a critical risk factor for the development of metabolic diseases, and its prevalence is increasing worldwide. Stem cell-based therapies have become a promising tool for therapeutic intervention. Among them are adipose-derived mes…